Pfizer testing pill aimed at preventing COVID-19 infection

Pfizer has started testing its potential COVID-19 treatment as a preventive medicine aimed at warding off the virus if a close contact gets it.

The drugmaker says it will study the pill it is developing in combination with a low dose of the HIV drug ritonavir in people who are at least 18 years old and live in the same household with someone who is infected. The pill aims to block a key enzyme that the virus needs to replicate. Pfizer plans to enroll 2,660 people in the late-stage study.

Researchers expect that the use of ritonavir will help slow the breakdown of the potential treatment so it remains active longer to help fight the virus.

MORE | What we know about the delta variant
EMBED More News Videos

ABC chief medical correspondent Dr. Jen Ashton explains what we know and don't know about the threat posed by the Delta variant of COVID-19.



MORE | Pfizer to ask for approval of COVID vaccine for kids in matter of days
EMBED More News Videos

Pfizer/BioNTech plans to ask for authorization of a COVID-19 vaccine for some children under 12 soon, bringing the US one step closer to offering protection to a population that has grown particularly vulnerable as the fall season gets underway.



Copyright © 2021 by The Associated Press. All Rights Reserved.